Search

Search Constraints

You searched for: Author/Creator Altshuler, David

Search Results

1. A null mutation in ANGPTL8 does not associate with either plasma glucose or type 2 diabetes in humans. Issue 1 (December 2016)

2. Association of Exome Sequences With Cardiovascular Traits Among Blacks in the Jackson Heart Study. (August 2016)

3. ATIM-44. A PHASE I FIRST-IN-HUMAN TRIAL OF TWO ADENOVIRAL VECTORS EXPRESSING HSV1-TK AND FLT3L FOR TREATING NEWLY DIAGNOSED RESECTABLE MALIGNANT GLIOMA: THERAPEUTIC REPROGRAMMING OF THE BRAIN IMMUNE SYSTEM. (11th November 2019)

4. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Issue 6 (June 2021)

7. First in Human Phase I Trial of Dual Vector (HSV1-TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High-Grade Glioma: Initial Results. (1st September 2019)

8. First in Human Phase I Trial of Dual Vector (HSV1‐TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High‐Grade Glioma: Initial Results. (September 2019)

9. From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline. Issue 1 (15th March 2018)